Peripheral Neuropathy Trial, Recruiting NCT07696312 Sponsor: Marmara University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07696312
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years
  • People who have been given a preliminary diagnosis of lumbar radicular pain (nerve-related lower back and leg pain) based on their medical history, a physical examination, and an MRI scan of the lower back
  • People who are already scheduled to have a procedure called a transforaminal epidural injection targeting one of three specific nerves in the lower back (the L4, L5, or S1 nerve root)

Who may not be able to join:

  • People whose clinical or procedural records are not accessible through the hospital system
  • People for whom relevant imaging records related to the treatment area are not available, where those records are needed
  • People who are unable to complete a standard pain scale rating or a physical leg-raise test due to memory or thinking difficulties, or due to a language barrier
  • People with blood clotting problems, including those with certain abnormal blood test results (INR above 1.5 or platelet count below 80,000/mm³), or those who cannot safely stop blood-thinning medications when required
  • People with an active infection anywhere in the body, or a skin problem at the planned injection site
  • People who are pregnant or breastfeeding
  • People with a known severe allergic reaction to the type of dye used in imaging procedures (iodinated contrast) or to local anaesthetic medications
  • People who have a worsening neurological condition or a serious nerve compression condition affecting bowel or bladder function (confirm with trial site)
  • People whose pain is prominent and roughly equal on both sides of the body, or who would need injections at more than one spinal level in the same session
  • People who have had an epidural injection containing local anaesthetic and/or steroid at the same spinal level within the past 6 weeks
  • People with an active condition affecting multiple nerves throughout the body
  • People whose nerve pain is coming from a spinal nerve other than L4, L5, or S1
  • People who would require sedation as a necessary part of the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: MİKDAT CAN KARABIYIK, Marmara University Faculty of Medicine ,Marmara University, Department of Physical Medicine and Rehabilitation

Phone: +90 537 91 92 156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marmara University
Registry
ClinicalTrials.gov
Start date
11 December 2025
Est. completion
1 September 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Diagnostic Performance of the Straight Leg Raise Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov